Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

703 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cautious handling of urine from moderate to severe COVID-19 patients.
Nomoto H, Ishikane M, Katagiri D, Kinoshita N, Nagashima M, Sadamasu K, Yoshimura K, Ohmagari N. Nomoto H, et al. Among authors: kinoshita n. Am J Infect Control. 2020 Aug;48(8):969-971. doi: 10.1016/j.ajic.2020.05.034. Epub 2020 Jun 2. Am J Infect Control. 2020. PMID: 32502614 Free PMC article. No abstract available.
Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.
Takaya S, Tsuzuki S, Hayakawa K, Kawashima A, Okuhama A, Kanda K, Suzuki T, Akiyama Y, Miyazato Y, Ide S, Nakamura K, Nomoto H, Nakamoto T, Hikida S, Tanuma J, Ohara K, Ito T, Baba T, Yamamoto K, Ujiie M, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Ohmagari N. Takaya S, et al. Among authors: kinoshita n. Epidemiol Infect. 2020 Oct 13;148:e250. doi: 10.1017/S0950268820002496. Epidemiol Infect. 2020. PMID: 33046159 Free PMC article.
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.
Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M, Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama H, Ohmagari N, Mizokami M. Sugiyama M, et al. Among authors: kinoshita n. Gene. 2021 Jan 15;766:145145. doi: 10.1016/j.gene.2020.145145. Epub 2020 Sep 14. Gene. 2021. PMID: 32941953 Free PMC article.
Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers.
Suzuki T, Hayakawa K, Ainai A, Iwata-Yoshikawa N, Sano K, Nagata N, Suzuki T, Wakimoto Y, Akiyama Y, Miyazato Y, Nakamura K, Ide S, Nomoto H, Nakamoto T, Ota M, Moriyama Y, Sugiki Y, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Ohmagari N. Suzuki T, et al. Among authors: kinoshita n. J Infect Chemother. 2021 Jan;27(1):120-122. doi: 10.1016/j.jiac.2020.09.006. Epub 2020 Sep 9. J Infect Chemother. 2021. PMID: 32988731 Free PMC article.
Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan.
Akiyama Y, Morioka S, Wakimoto Y, Kawashima A, Kanda K, Okuhama A, Suzuki T, Miyazato Y, Nomoto H, Ide S, Nakamoto T, Nakamura K, Ota M, Moriyama Y, Takaya S, Yamada K, Taguchi M, Sugito E, Izuka S, Ishiguro K, Kobayashi T, Miyake W, Kubota S, Ishikane M, Kinoshita N, Yamamoto K, Ujiie M, Kutsuna S, Hayakawa K, Saito S, Ohmagari N. Akiyama Y, et al. Among authors: kinoshita n. Intern Med. 2020 Dec 15;59(24):3131-3133. doi: 10.2169/internalmedicine.5614-20. Epub 2020 Nov 2. Intern Med. 2020. PMID: 33132334 Free PMC article.
No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
Nomoto H, Kutsuna S, Okuma K, Kuramitsu M, Tezuka K, Ikebe E, Saito S, Kinoshita N, Terada M, Endo M, Suzuki T, Miyazato Y, Nakamoto T, Inada M, Hamaguchi I, Ohmagari N. Nomoto H, et al. Among authors: kinoshita n. J Infect Chemother. 2021 Apr;27(4):653-655. doi: 10.1016/j.jiac.2021.01.004. Epub 2021 Jan 15. J Infect Chemother. 2021. PMID: 33487533 Free PMC article.
Positive Ratio of Polymerase Chain Reaction (PCR) and Validity of Pre-Screening Criteria at an Outpatient Screening Center during the Early Phase of the COVID-19 Epidemic in Japan.
Ide S, Hayakawa K, Yamamoto K, Tsuzuki S, Tanuma J, Ohara K, Yamada G, Okuhama A, Kanda K, Suzuki T, Akiyama Y, Miyazato Y, Nakamura K, Nomoto H, Nakamoto T, Ujiie M, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Tanaka K, Ohmagari N. Ide S, et al. Among authors: kinoshita n. Jpn J Infect Dis. 2021 Sep 22;74(5):481-486. doi: 10.7883/yoken.JJID.2020.813. Epub 2021 Feb 26. Jpn J Infect Dis. 2021. PMID: 33642432 Free article.
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies.
Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N. Inada M, et al. Among authors: kinoshita n. J Infect Chemother. 2021 Jul;27(7):1063-1067. doi: 10.1016/j.jiac.2021.04.017. Epub 2021 Apr 24. J Infect Chemother. 2021. PMID: 33962861 Free PMC article.
Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?
Yamamoto K, Nagashima M, Yoshida I, Sadamasu K, Kurokawa M, Nagashima M, Kinoshita N, Maeda K, Takasaki J, Teruya K, Ohmagari N. Yamamoto K, et al. Among authors: kinoshita n. J Infect Chemother. 2021 Aug;27(8):1273-1275. doi: 10.1016/j.jiac.2021.05.006. Epub 2021 May 12. J Infect Chemother. 2021. PMID: 34023222 Free PMC article.
703 results